Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nexera Medical has developed and commercialized reusable antimicrobial respiratory masks, notably the Guardian FFP2 RD mask. These masks incorporate advanced antimicrobial technologies such as Agion AM embedded in nonwoven fibers to provide extended protection against infectious agents. The company’s products have received European Union clearance and CE marking for use in Europe; they are also available in South America and Canada but not the U.S.[1][3][5] No clinical trial data is reported as these are regulated as devices rather than drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nexera Medical.